# Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients

> **NCT01441752** · PHASE3 · COMPLETED · sponsor: **xuling** · enrollment: 349 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** TCM
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01441752
- **Lead sponsor:** xuling
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 349 (ACTUAL)
- **Last updated:** 2016-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441752, "Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01441752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*